The Management of Chronic Gynecologic Conditions During COVID and Beyond

Supported by: AbbVie Inc.

Experts discuss management of women’s health including chronic pelvic pain resulting from endometriosis and heavy menstrual bleeding from uterine fibroids. They also discuss ways to help improve patient-provider communications and overcome the normalization associated with non-malignant gynecological conditions.

EP1: Enhancing Patient-Provider Dialogue in Telehealth and Beyond

March 15th 2021

Supported by: AbbVie

EP2: Screening Tools and Diagnosis for Endometriosis-Associated Pain

March 15th 2021

Supported by: AbbVie

EP3: Individualized Treatment Goals for EM-Associated Pain

March 15th 2021

Supported by: AbbVie

EP4: Enhancing Communication in Patients With Unresolved EM Symptoms

March 15th 2021

Supported by: AbbVie

EP5: Making Informed Decisions to Treat Endometriosis

March 15th 2021

Supported by: AbbVie

EP6: Risks/Benefits of Medical Treatment for EM-Associated Pain

March 15th 2021

Supported by: AbbVie

EP7: Risks/Benefits of Surgical Treatment for EM-Associated Pain

March 15th 2021

Supported by: AbbVie

EP8: ACOG Recommendations for Management of HMB Associated With UF

March 15th 2021

Supported by: AbbVie

EP9: Risks/Benefits of Surgical Treatment for HMB Associated With UF

March 15th 2021

Supported by: AbbVie

EP10: Risks/Benefits of Medical Treatment for HMB Associated With UF

March 15th 2021

Supported by: AbbVie

ABBV-US-00348-MC v1.0 Approved 04/2021